Literature DB >> 9125555

Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice.

Y Shibata1, L A Foster, W J Metzger, Q N Myrvik.   

Abstract

Intravenous (i.v.) administration of phagocytosable chitin particles (1 to 10 microm) in C57BL/6 mice and SCID mice primed alveolar macrophages (Mphi) within 3 days to yield up to a 50-fold increase in their oxidative burst when elicited in vitro with phorbol myristate acetate (PMA). C57BL/6 mice pretreated with monoclonal antibodies (MAbs) against mouse gamma interferon (IFN-gamma) or NK1.1 showed a markedly decreased level of alveolar Mphi priming following injection of chitin particles. To confirm IFN-gamma production in vitro, spleen cells isolated from normal C57BL/6 mice and SCID mice were cultured with chitin particles. Significant IFN-gamma production was observed following stimulation with chitin but not with chitosan or latex beads. When spleen cells were treated with anti-NK1.1 MAb, IFN-gamma production was significantly inhibited. Another set of experiments showed that when C57BL/6 mice were pretreated i.v. with a small dose IFN-gamma, a higher level of priming was induced with not only phagocytosable chitin particles but also phagocytosable chitosan and even latex beads. Likewise, the spleen cell cultures preconditioned with IFN-gamma provided an up-regulation of IFN-gamma production by these phagocytosable particles. Taken together, the in vivo and in vitro results suggest that (i) the alveolar Mphi priming mechanism is due, at least in part, to direct activation of Mphi by IFN-gamma, which is produced by NK1.1+ CD4- cells; (ii) IFN-gamma would have an autocrine-like effect on Mphi and make them more responsive to particle priming; and (iii) phagocytosis of particulates, probably by a postmembrane event such as interiorization, appears to be important for the up-regulation of alveolar Mphi priming and IFN-gamma production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125555      PMCID: PMC175208          DOI: 10.1128/iai.65.5.1734-1741.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

2.  Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines.

Authors:  M J Skeen; M A Miller; T M Shinnick; H K Ziegler
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

3.  A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity.

Authors:  G A Warr
Journal:  Biochem Biophys Res Commun       Date:  1980-04-14       Impact factor: 3.575

4.  Prostaglandin E2 release triggered by phagocytosis of latex particles. A distinct association with prostaglandin synthase isozymes in bone marrow macrophages.

Authors:  Y Shibata
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

5.  Cloning of a new cytokine that induces IFN-gamma production by T cells.

Authors:  H Okamura; H Tsutsi; T Komatsu; M Yutsudo; A Hakura; T Tanimoto; K Torigoe; T Okura; Y Nukada; K Hattori
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

6.  Macrophage colony-stimulating factor-induced bone marrow macrophages do not synthesize or release prostaglandin E2.

Authors:  Y Shibata; D R Bjorkman; M Schmidt; Y Oghiso; A Volkman
Journal:  Blood       Date:  1994-06-01       Impact factor: 22.113

7.  Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit.

Authors:  A Snijders; C M Hilkens; T C van der Pouw Kraan; M Engel; L A Aarden; M L Kapsenberg
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

Review 8.  Antibiotics that inhibit fungal cell wall development.

Authors:  M Debono; R S Gordee
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

Review 9.  The fungal cell wall as a drug target.

Authors:  N H Georgopapadakou; J S Tkacz
Journal:  Trends Microbiol       Date:  1995-03       Impact factor: 17.079

10.  A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages.

Authors:  L H Allen; A Aderem
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  57 in total

1.  A method for oral DNA delivery with N-acetylated chitosan.

Authors:  Eriko Kai; Takahiro Ochiya
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

2.  Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.

Authors:  Yong Xie; Nan-Jin Zhou; Yan-Feng Gong; Xiao-Jiang Zhou; Jiang Chen; Si-Juan Hu; Nong-Hua Lu; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

3.  Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats.

Authors:  Bing Liu; Wan-Shun Liu; Bao-Qin Han; Yu-Ying Sun
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

4.  Adjuvant activity of emulsan, a secreted lipopolysaccharide from acinetobacter calcoaceticus.

Authors:  Bruce Panilaitis; Atul Johri; Walter Blank; David Kaplan; Juliet Fuhrman
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 5.  Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

Authors:  Chun Geun Lee; Carla A Da Silva; Charles S Dela Cruz; Farida Ahangari; Bing Ma; Min-Jong Kang; Chuan-Hua He; Seyedtaghi Takyar; Jack A Elias
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 6.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

7.  Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB.

Authors:  Zhang Songjiang; Wu Lixiang
Journal:  AAPS PharmSciTech       Date:  2009-07-16       Impact factor: 3.246

Review 8.  Fungal Exposure and Asthma: IgE and Non-IgE-Mediated Mechanisms.

Authors:  Zhonghua Zhang; Tiina Reponen; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

9.  Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus.

Authors:  Dong Li
Journal:  Virol J       Date:  2010-06-12       Impact factor: 4.099

Review 10.  Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers.

Authors:  Riccardo A A Muzzarelli
Journal:  Mar Drugs       Date:  2010-02-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.